Hester Biosciences partners with Gujarat Government & OmniBRx for manufacturing COVID vaccine
Hester Biosciences is tying up with Gujarat Biotechnology Research Centre (Government of Gujarat) along with OmniBRx for manufacturing the COVID vaccine.
A triparty agreement has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the COVID vaccine after acquiring technology from Bharat Biotech.
The discussions are currently ongoing with Bharat Biotech towards reviewing the infrastructure at Hester Biosciences, technology adaption process as well as the regulatory compliances.
Reacting to this, the company’s stock today increased by 19.67 per cent and made an intraday high of Rs 2,955.90 per share.
Hester Biosciences manufactures poultry and large animal vaccines. It is also engaged in the trading of poultry health products and large animal health products. Its segments include poultry division and large animal division.
According to BSE data, the stock traded at a P/E multiple of 58.29 and a price-to-book ratio of 9.76. The stock has a 52-week high and a 52-week low of Rs 2,955.90 and Rs 1,070, respectively.
At 12 pm on Monday, the stock of the company was trading at Rs 2,838.20, up by 14.90 per cent on BSE.